🔎 Trials Near Me

Utama › Kanser Pankreas › California

Kajian klinikal Kanser Pankreas di California

91 kajian untuk Kanser Pankreas sedang mencari peserta di lokasi di California.

Bandar di California

Teks kajian rasmi (Bahasa Inggeris)

Distance-Based Exercise to Preserve Function and Prevent Disability

  • Kaiser Permanente Dublin, Dublin
  • Kaiser Permanente-Fremont, Fremont
  • Kaiser Permanente Fresno Orchard Plaza, Fresno
  • dan 10 lagi
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07059884

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

  • City of Hope National Medical Center, Duarte
  • University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla
  • UCLA Department of Medicine-Hematology/Oncology, Los Angeles
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06465069

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

  • City of Hope, Duarte
  • University of California San Diego, San Diego
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07562152

Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma

  • City of Hope Duarte, Duarte
  • University of California at Los Angeles, Santa Monica
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07529808

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

  • City of Hope Comprehensive Cancer Center, Duarte
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
  • City of Hope at Irvine Lennar, Irvine
  • dan 2 lagi
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05372614

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  • City of Hope, Duarte
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06172478

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

  • City of Hope National Medical Center, Duarte
  • City of Hope at Irvine Lennar, Irvine
  • Ronald Reagan UCLA Medical Center, Los Angeles
  • dan 3 lagi
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07090499

A Study of PHN-012 in Patients With Advanced Solid Tumors

  • PHN-012-001 Site, Los Angeles
  • PHN-012-001 Site, San Diego
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07127874

Pancreatic Cancer Detection Consortium

  • City of Hope Medical Center, Monrovia
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT06388967

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

  • City of Hope Cancer Center-Duarte, Duarte
  • Providence Medical Foundation, Santa Rosa
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07277413

DESTINY-PANTUMOUR04

  • Research Site, San Diego
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 130 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07124000

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

  • University of California San Diego, La Jolla
  • Stanford University, Palo Alto
  • UCLA Medical Center, Santa Monica
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT04981119

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

  • UC San Diego Medical Center - Encinitas, Encinitas
  • Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
  • UCI Health - Irvine, Irvine
  • dan 14 lagi
Mengambil pesertaFasa 2/3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06989437

A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

  • Kivu Trial Site, Santa Monica
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT07229313

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

  • UC San Diego Moores Cancer Center, La Jolla
  • Cedars-Sinai Cancer at Cedars-Sinai Medical Center, Los Angeles
  • University of California, Los Angeles, Los Angeles
  • dan 3 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT07252232

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • UC IRVINE Health, Orange
  • UC Davis Comprehensive Cancer Center, Sacramento
  • Stanford Cancer Institute, Stanford
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06128551

UCSF PANC Cyst Registry

  • University of California, San Francisco, San Francisco
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT04291651

A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer

  • Crosson Cancer Institute at Providence St. Jude Medical Center in Fullerton, Fullerton
  • UCI Health - Irvine, Irvine
  • Cedars-Sinai - Cedars-Sinai Medical Center, Los Angeles
  • dan 2 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07409272

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

  • UC San Diego Moores Cancer Center, La Jolla
  • Cedars-Sinai Cancer at Cedars-Sinai Medical Center, Los Angeles
  • UCLA Hematology/Oncology- Santa Monica, Los Angeles
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06445062

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

  • Investigative Site US051, Duarte
  • Investigative Site US085, Fullerton
  • Investigative Site US054, La Jolla
  • dan 7 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07522073

Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts

  • University of California, San Francisco, San Francisco
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT06271291

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

  • Local Institution - 0096, San Francisco
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Sep 2026 · NCT07492680

CREO - Microwave Ablation Feasibility Study

  • Cedars Sinai, Los Angeles
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT07817147

Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study

  • Children's Hospital Los Angeles, Los Angeles
  • Cedars Sinai Medical Center, Los Angeles
  • UCSF Benioff Children's Hospital Oakland, Oakland
  • dan 1 lagi
Mengambil pesertaKajian pemerhatian
Sehingga umur 17 · Semua jantina · Dikemas kini 11 Sep 2026 · NCT06651580

Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach

  • City of Hope, Duarte
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Sep 2026 · NCT05764720

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

  • USC/Norris Comprehensive Cancer Center, Los Angeles
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT06440005

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

  • University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Sep 2026 · NCT06400472

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

  • Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank
  • UC San Diego Moores Cancer Center, La Jolla
  • Loma Linda University Medical Center, Loma Linda
  • dan 5 lagi
Mengambil pesertaKajian pemerhatian
Umur 50 hingga 75 · Semua jantina · Dikemas kini 4 Sep 2026 · NCT04239573

Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors

  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
  • UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT05687123

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer

  • START- Los Angeles, Los Angeles
  • Cedars-Sinai Medical Center, Los Angeles
  • Valkyrie Clinical Trials, Los Angeles
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT07644559

PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)

  • Hoag Memorial Hospital Presbyterian, Newport Beach
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Sep 2026 · NCT06673017

The Vanguard Study: Testing a New Way to Screen for Cancer

  • Kaiser Permanente-Division of Research, Pleasanton
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 45 hingga 75 · Semua jantina · Dikemas kini 2 Sep 2026 · NCT06995898

Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

  • City of Hope Comprehensive Cancer Center, Duarte
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
  • City of Hope at Irvine Lennar, Irvine
  • dan 2 lagi
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Sep 2026 · NCT04172532

Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers

  • Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 31 Ogo 2026 · NCT05497531

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

  • University of Southern California, Los Angeles
  • Cedars-Sanai Medical Center - Samuel Oschin Comprehensive Cancer, Los Angeles
  • Cedars-Sanai Medical Center, Los Angeles
  • dan 1 lagi
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 27 Ogo 2026 · NCT06582017

Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer

  • Cedars-Sinai, Los Angeles
Mengambil peserta
Umur 18 hingga 120 · Semua jantina · Dikemas kini 27 Ogo 2026 · NCT06698458

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

  • Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
  • AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
  • Alta Bates Summit Medical Center-Herrick Campus, Berkeley
  • dan 20 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT06958328

Understanding New Cachexia Subtypes Through Observational Epidemiological Research

  • Kaiser Permanente Northern California, Pleasanton
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT07776353

AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer

  • UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT07619313

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.